Skip to content

Exactech GPS Total Shoulder Application 3.2mm Vix Bit… recallZ-0603-2018 · Exactech, Inc. · initiated Jul 11, 2017

Class II Terminated All recalls posted in January 2018

Is my device affected?

  1. Compare the model, catalog and lot or serial numbers on your device or its packaging with the code information below. A recall usually covers only specific models or lots.
  2. If yours is listed, follow the instructions from Exactech, Inc. or your healthcare provider. The company's action is summarized under what the company is doing.
  3. Do not stop using a prescribed or implanted device on your own — talk to your healthcare provider first.

Where to find your model and lot numbers · What recall classes and statuses mean

Why it was recalled

Vix Bit may fracture during use.

FDA root cause category: Nonconforming Material/Component

What the company is doing

Customers were notified on approximately 07/11/2017. Instructions included cease distribution of the affected product, notify customers if further distributed, identify and quarantine any product in inventory and complete and return the Recall Inventory Response Form. For further questions, please call (800) 392-2832.

Recall details

Recall number
Z-0603-2018
Recall class
Class II
Status
Terminated
Initiated by the company
Jul 11, 2017
Posted by the FDA
Jan 18, 2018
Recalling firm
Exactech, Inc.
Quantity
41 devices
Product code
OLO
FDA submissions
K162567
Distribution
Worldwide Distribution: US states of Florida and California, Australia, France, Spain, and United Kingdom.

Product description

Exactech GPS Total Shoulder Application 3.2mm Vix Bit Orthopedic surgical tool

Code information (models, lots, serial numbers)

Catalog No. 531-15-08, Lot No. 75296003, 80129003, 81327001

Other devices under the same FDA submission

7 devices cleared under K162567 — the recall does not name any of them by identifier. One submission often covers many models, so they may or may not be affected.

Sources and updates

How recalls are matched to devices · Editorial policy · Report an error on this page